Rockwell Automation vs Sana Biotechnology Inc — how do they compare? Rockwell Automation trades at $466.2 (market cap $51.04B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Rockwell Automation is far larger — about 58.4× Sana Biotechnology Inc's market cap, and Rockwell Automation pays a 1.2% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| ROK | SANA | |
|---|---|---|
Market Cap | $51.04B | $873.84M |
Sector | Industrials | Health |
52-Week High | $495.08 | $5.92 |
52-Week Low | $328.67 | $2.68 |
Enterprise Value | $54.67B | $848.03M |
Dividend Yield | 1.2% | — |
Trailing returns across standard periods
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →